The HIF1α-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element

Oncogene

Volumn 28, Issue 41, 2009, Pages 3671-3680

  Farrall, A L ^a,b   Whitelaw, M L ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Centre for the Molecular Genetics of Development   (Australia)

Author keywords

BNIP3; Cancer; Cell death; HIF1a; Hypoxia; SIM2

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN BNIP3; SINGLE MINDED 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BNIP3 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1BETA; MEMBRANE PROTEIN; ONCOPROTEIN; SIM2 PROTEIN, HUMAN;

ARTICLE; AUTOPHAGY; CARCINOGENESIS; CARCINOMA CELL; CELL DEATH; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE REPRESSION; HUMAN; HUMAN CELL; HYPOXIA; MALE; MICROARRAY ANALYSIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; ANIMAL; CELL HYPOXIA; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PROSTATE TUMOR; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ADENOVIRIDAE;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DEATH; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MEMBRANE PROTEINS; MICE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVATION;

EID: 70350064297     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.228     Document Type: Article

References (50)

1. Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M et al. (2005). Upregulation of BNIP3 by 5-aza-20-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. J Gastroenterol 40: 504-510.
2. Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M et al. (2005). Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res 11: 3094-3101.
3. Aleman MJ, DeYoung MP, Tress M, Keating P, Perry GW, Narayanan R. (2005). Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. Proc Natl Acad Sci USA 102: 12765-12770.
4. Azad MB, Chen Y, Henson ES, Cizeau J, McMillan-Ward E, Israels SJ et al. (2008). Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 4: 195-204.
5. Bacon AL, Fox S, Turley H, Harris AL. (2007). Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer. Oncogene 26: 132-141.
6. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B et al. (1994). Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79: 341-351.
7. Bruick RK. (2000). Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 97: 9082-9087.
8. Burton TR, Gibson SB. (2009). The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 16: 515-523.
9. Chandran U, Dhir R, Ma C, Michalopoulos G, Becich M, Gilbertson J. (2005). Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 5: 45.
10. Chrast R, Scott HS, Chen H, Kudoh J, Rossier C, Minoshima S et al. (1997). Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region. Genome Res 7: 615-624.
11. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, Kondo S. (2004). Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64: 4286-4293.
12. De Angelis PM, Fjell B, Kravik KL, Haug T, Tunheim SH, Reichelt W et al. (2004). Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. Int J Oncol 24: 1279-1288.
13. DeYoung MP, Scheurle D, Damania H, Zylberberg C, Narayanan R. (2002). Down's syndrome-associated single minded gene as a novel tumor marker. Anticancer Res 22: 3149-3157.
14. DeYoung MP, Tress M, Narayanan R. (2003a). Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors. Proc Natl Acad Sci USA 100: 4760-4765.
15. DeYoung MP, Tress M, Narayanan R. (2003b). Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. Cancer Lett 200: 25-31.
16. Drabsch Y, Hugo H, Zhang R, Dowhan DH, Miao YR, Gewirtz AM et al. (2007). Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci USA 104: 13762-13767.
17. Ema M, Morita M, Ikawa S, Tanaka M, Matsuda Y, Gotoh O et al. (1996b). Two new members of the murine Sim gene family are transcriptional repressors and show different expression patterns during mouse embryogenesis. Mol Cell Biol 16: 5865-5875.
18. Erkan M, Kleeff J, Esposito I, Giese T, Ketterer K, Buchler MW et al. (2005). Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24: 4421-4432.
19. Goshu E, Jin H, Fasnacht R, Sepenski M, Michaud JL, Fan CM. (2002). Sim2 mutants have developmental defects not overlapping with those of Sim1 mutants. Mol Cell Biol 22: 4147-4157.
20. Halvorsen OJ, Rostad K, Oyan AM, Puntervoll H, Bo TH, Stordrange L et al. (2007). Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer. Clin Cancer Res 13: 892-897.
21. Ishiguro M, Iida S, Uetake H, Morita S, Makino H, Kato K et al. (2007). Effect of combined therapy with low-dose 5-aza-20-deoxycytidine and irinotecan on colon cancer cell line HCT-15. Ann Surg Oncol 14: 1752-1762.
22. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
23. Kewley RJ, Whitelaw ML, Chapman-Smith A. (2004). The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol 36: 189-204.
24. Kwak HI, Gustafson T, Metz RP, Laffin B, Schedin P, Porter WW. (2007). Inhibition of breast cancer growth and invasion by single-minded 2s. Carcinogenesis 28: 259-266.
25. Laffin B, Wellberg E, Kwak HI, Burghardt RC, Metz RP, Gustafson T et al. (2008). Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2. Mol Cell Biol 28: 1936-1946.
26. Lee H, Paik SG. (2006). Regulation of BNIP3 in normal and cancer cells. Mol Cells 21: 1-6.
27. Levine B. (2007). Cell biology: autophagy and cancer. Nature 446: 745-747.
28. Mahon PC, Baril P, Bhakta V, Chelala C, Caulee K, Harada T et al. (2007). S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 67: 6786-6795.
29. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. (2007). Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8: 741-752.
30. Mellor HR, Harris AL. (2007). The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev 26: 553-566.
31. Metz RP, Kwak HI, Gustafson T, Laffin B, Porter WW. (2006). Differential transcriptional regulation by mouse single-minded 2s. J Biol Chem 281: 10839-10848.
32. Mizushima N, Yoshimori T. (2007). How to interpret LC3 immuno-blotting. Autophagy 3: 542-545.
33. Moffett P, Reece M, Pelletier J. (1997). The murine Sim-2 gene product inhibits transcription by active repression and functional interference. Mol Cell Biol 17: 4933-4947.
34. Muller P, Janovjak H, Miserez AR, Dobbie Z. (2002). Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-4, 1376, 1378-1379
35. Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K et al. (2005). Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clin Cancer Res 11: 1021-1027. (Pubitemid 40175749)
36. Okami J, Simeone DM, Logsdon CD. (2004). Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 64: 5338-5346.
37. Probst MR, Fan CM, Tessier-Lavigne M, Hankinson O. (1997). Two murine homologs of the Drosophila single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator protein. J Biol Chem 272: 4451-4457.
38. Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM. (2009). Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 28: 334-344.
39. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. (1999). p42/ p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcrip-tional activity of HIF-1. J Biol Chem 274: 32631-32637.
40. Semenza GL. (2000). HIF-1 and human disease: one highly involved factor. Genes Dev 14: 1983-1991.
41. Shamblott MJ, Bugg EM, Lawler AM, Gearhart JD. (2002). Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene. Dev Dyn 224: 373-380.
42. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. (2001). HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 61: 6669-6673.
43. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T et al. (2002). Large-scale analysis of the human and mouse transcrip-tomes. Proc Natl Acad Sci USA 99: 4465-4470.
44. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. (2007a). BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 27: 6229-6242.
45. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA et al. (2005). Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8: 393-406.
46. Woods S, Farrall A, Procko C, Whitelaw ML. (2008). The bHLH/Per-Arnt-Sim transcription factor SIM2 regulates muscle transcript myomesin2 via a novel, non-canonical E-box sequence. Nucleic Acids Res 36: 3716-3727.
47. Woods SL, Whitelaw ML. (2002). Differential activities of murine single minded 1 (SIM1) and SIM2 on a hypoxic response element. Cross-talk between basic helix-loop-helix/per-Arnt-Sim homology transcription factors. J Biol Chem 277: 10236-10243.
48. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L et al. (2004). Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790-2799.
49. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB et al. (2008). Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903.
50. Zhou J, Schmid T, Schnitzer S, Brune B. (2006). Tumor hypoxia and cancer progression. Cancer Lett 237: 10-21.